HWN Suggests

Magnetic Resonance Imaging in Prostate Cancer Screening

The results of this systematic review and meta-analysis suggest that prostate MRI with targeted biopsies is an effective strategy for the early detection of prostate cancer. We found that MRI mitigates pitfalls of standard PSA-based strategies, as it can be associated with fewer unnecessary biopsies and helps to avoid the detection of insignificant cancers while not compromising significant disease detection. Our results highlight the need to reassess our approach to population-based screening; however, the optimal setup of MRI and biopsy scheme in the screening process requires further evaluation.

read full article

Featured

 MRI scanning could lead to major cut in prostate cancer deaths, UK study finds

Research found MRI is significantly more accurate than current tests, which are linked to overdiagnosis and overtreatment.

Articles of Interest

Prostate MRI: A More Accurate and Less Invasive Way to Detect Cancer

As the second most common cancer affecting men worldwide, prostate cancer is a haunting reality for many men1. But it doesn’t have to be. Early detection significantly improves prognosis, and recent advances in medical imaging technology, like prostate MRI (magnetic resonance imaging), machine learning, and artificial intelligence, have made early detection more accessible than ever.

The Role of MRI in Prostate Cancer, Current and Future Directions

There has been an increasing role of magnetic resonance imaging (MRI) in the management of prostate cancer with the advances in technology. These include the introduction of functional sequences (e.g., dynamic contrast-enhancement [DCE] MRI and diffusion-weighted imaging [DWI]), high-field magnets (e.g., 3-Tesla), whole-body MRI, and hybrid imaging (e.g., integrated positron emission tomography [PET]/MRI). MRI plays key roles in many steps of prostate cancer management, including detection and diagnosis, MRI-guided biopsy, staging, active surveillance, treatment planning, evaluation of biochemical recurrence, and assessment of metastatic disease.

Considering Prostate Cancer Screening Options? A Prostate MRI May Save You From an Unnecessary Biopsy

Not only is a prostate MRI as accurate as a biopsy at detecting prostate cancers, but it can also tell how advanced the cancer is and if it has spread to other parts of the body. A prostate MRI can also detect other prostate conditions, like infections or benign prostatic hyperplasia (BPH). And it is better than prostate biopsies at differentiating between clinically significant and insignificant cancers.

Hopes that MRI scans can screen men for prostate cancer

The scans proved far more accurate at diagnosing cancer than blood tests, which look for high levels of a protein called PSA. MRI picked up some serious cancers that would have been missed by PSA alone. At present there is no national screening programme because PSA is considered too unreliable, although men over 50 can request a PSA test.

MRI in Prostate Cancer Screening: A Review and Recommendations, From the AJR Special Series on Screening

Traditional PSA-based screening for prostate cancer (PCa) is challenged by an unfavorable benefit-to-harm ratio from underdiagnosis of clinically significant cancers, overdiagnosis of indolent cancers, and unnecessary biopsies, despite demonstrated reductions in PCa mortality. Inclusion of MRI in screening algorithms helps address these limitations by improving risk stratification of men suspected to have PCa and enabling targeted biopsies

MRI screening for prostate cancer shows promise

Combining MRI and blood test results struck a balance between finding serious cancers and avoiding unnecessary biopsies (for low-risk cancers). Ultrasound offered no benefit over blood tests or MRI. The researchers suggest MRI tests could be used in a future prostate screening programme, though more research is needed.

MRI-first strategy for prostate cancer detection proves to be safe

No need for a biopsy with negative MRI findings. This approach, in which normal MRI findings are followed by regular urological checks, did in fact prove to be sufficiently reliable: The study found that 96 percent of patients with a normal MRI result would not go on to develop aggressive prostate cancer within three years.

Prostate Cancer Detection and Diagnosis: The Role of MR and its Comparison to other Diagnostic Modalities – A Radiologist's Perspective

Prostate MRI is now recognized as the most useful and accurate modality to detect, characterize and stage prostate cancer.

Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only

The avoidance of systematic biopsy in favor of MRI-directed targeted biopsy for screening and early detection in persons with elevated PSA levels reduced the risk of overdiagnosis by half at the cost of delaying detection of intermediate-risk tumors in a small proportion of patients.

Resources

Inside Radiology

The MRI scan can help find a cancer of the prostate gland, especially if you have elevated or rising PSA. If a cancer has already been found, the MRI images can show whether it has spread outside the prostate gland or not. This can have a very important impact on whether or not you have treatment, and if so, which type of treatment you receive.